Blog Archive

0

Canada secures millions of vaccine doses, but it likely won’t be federally mandated, officials say

Yahoo News Canada is committed to providing our readers with the most accurate and recent information on all things coronavirus. We know things change quickly, including some possible information in this story. For the latest on COVID-19, we encourage our readers to consult online resources like Canada’s public health website, World Health Organization, as well as our own Yahoo Canada homepage.

As cases of COVID-19 continue to spread around the world, Canadians seem to be increasingly concerned about their health and safety.

Currently, there are more than 4,800 active cases of COVID-19 in Canada (with more than 125,000 diagnoses so far) and 9,000 deaths. Nearly 90 per cent of the country’s reported COVID-19 cases have recovered.

Check back for the latest updates on the coronavirus outbreak in Canada.

For a full archive of the first month of the pandemic, please check our archive of events.

August 31

Read More
  • August 31, 2020
0

GOP senators consider $600 extension; US orders 100 million vaccine doses from Pfizer; California cases top NY

The U.S. government has placed an initial order for 100 million doses of a vaccine candidate being developed by Pfizer and a German firm, BioNTech, for $1.95 billion, the companies announced Wednesday.

The U.S. can acquire up to 500 million additional doses, the statement said.

Meanwhile, federal unemployment benefits are taking a hit at a time when more states are abruptly pausing their reopening plans. The $600 weekly jobless benefits bonus, approved in March, is about to expire and likely won’t be extended or replaced before next month.

The U.S. has been averaging more than 60,000 new cases daily for multiple weeks, and hospitalizations have climbed to totals not seen in three months. A USA TODAY analysis of Johns Hopkins data through late Tuesday shows 10 states set seven-day records for new cases while five states had a record number of deaths over the period.

📈 Today’s stats: The U.S.

Read More
0

Pfizer hopes for October vaccine OK as US orders 100M doses; CDC director ‘absolutely’ wants grandkids back in school

The U.S. government has placed an initial order for 100 million doses of a vaccine candidate being developed by Pfizer and a German firm, BioNTech, for $1.95 billion, the companies announced Wednesday.

The U.S. can acquire up to 500 million additional doses, the statement said.

Meanwhile, federal unemployment benefits are taking a hit at a time when more states are abruptly pausing their reopening plans. The $600 weekly jobless benefits bonus, approved in March, is about to expire and likely won’t be extended or replaced before next month.

The U.S. has been averaging more than 60,000 new cases daily for multiple weeks, and some states are seeing hospitalization rates soar. A USA TODAY analysis of Johns Hopkins data through late Tuesday shows 10 states set seven-day records for new cases while five states had a record number of deaths over the period.

📈 Today’s stats: The U.S. has more than

Read More
0

UK buying 90 million coronavirus vaccine doses

LONDON — British officials say they have signed a deal to buy 90 million doses of experimental coronavirus vaccines being developed by the pharmaceutical giant Pfizer and others.

The British government said in a statement Monday that it had secured access to a vaccine candidate being developed by a Pfizer and BioNTech, in addition to another experimental vaccine researched by Valneva. Britain had previously signed a deal with AstraZeneca to provide 100 million doses of the coronavirus vaccine being tested by Oxford University, which is expected to announce further results later Monday.

“Millions of people could be vaccinated against coronavirus,” the government statement said, citing the three different vaccines it has now invested in.

Although it is still unclear which if any of the vaccines will ultimately prove effective against the virus, Britain and other rich countries are already investing in the vaccines to ensure there is enough manufacturing capacity

Read More